But with growth comes responsibility
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: a 52-week open-label, randomized phase III trial
What the evidence supports The peer-reviewed literature on MIC-B12 addresses several mechanisms relevant to longevity and wellness including methylation, B12 metabolism, and lipid utilization
Users in community sources commonly describe morning injection timing and site rotation as factors that reduce reaction frequency
It also provides practical and case-driven opinions and recommendations on the optimal use of GLP-1RAs by discussing important patient factors and clinical considerations that will help to identify those who are most likely to benefit from this class of agents
However, semaglutide, the active ingredient in both, can treat diabetes and obesity